Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE greenlights Consilient Health’s Elmiron for bladder pain syndrome

November 14, 2019
Sales and Marketing NICE, consilient health, elmiron, pharma

NICE has chosen to recommend Consilient Health’s Elmiron (pentosan polysulfate sodium) for the treatment of bladder pain syndrome (BPS), it …

News
merckentranceweb

MSD’s proposed sale of French manufacturing plant puts over 200 jobs in jeopardy

November 14, 2019
Manufacturing and Production France, MSD, pharma

MSD has announced its plans to put its Centre de Mirabel production facility in Riom, France up for sale – …

News
smart-watch-2845072_640

Wearable tech market set to double to $54 billion by 2023, report says

November 13, 2019
Research and Development, Sales and Marketing pahrma, wearble technology

A new report from GlobalData has revealed that the market for wearable technology in healthcare is expected to more than …

News
white_and_ford

Abbott CEO to step down after 21 years

November 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, appointment

After more than two decades at the head of the company, it has emerged that Miles D White (pictured, right) …

News
vertex-headquarters

Vertex’s cystic fibrosis portfolio to be made available across Northern Ireland and Wales

November 13, 2019
Research and Development, Sales and Marketing Kalydeco, NHS, Orkambi, Symkevi, Vertex, pharma

After drawn out negotiations and much discontent among cystic fibrosis (CF) patients and their advocates, Vertex has announced that a …

News
shutterstock_273326141

Mylan and Upjohn merger will create a new entity: Viatris

November 13, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Pfizer, Upjohn, Viatris, pharma

The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …

News

GSK’s Nucala meets Phase 3 goal in reducing hypereosinophilic syndrome flare-ups

November 13, 2019
Research and Development GSK, Nucala, pharma

GlaxoSmithKline has unveiled new Phase 3 data for its IL-5 inhibitor Nucala (mepolizumab), revealing that the therapy met its primary …

News

Pfizer’s tofacitinib hits main goal in Phase 3 juvenile idiopathic arthritis study

November 12, 2019
Manufacturing and Production, Research and Development Pfizer, pharma, tofacitinib

Pfizer has lifted the lid on new Phase 3 data exploring the efficacy of tofacitinib in the treatment of juvenile …

News
eisa0008_web

Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer

November 12, 2019
Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma

Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …

News
msd

MSD secures EU approval for its Zaire Ebola vaccine Ervebo

November 12, 2019
Manufacturing and Production, Sales and Marketing Ebola, Ervebo, MSD, pharma

MSD has scored approval from the European Commission for Ervebo, the company’s Zaire Ebola vaccine, for the prevention of Ebola …

News

Novartis’ Kisqali approved for NHS Scotland in most common advanced breast cancer

November 12, 2019
Manufacturing and Production, Sales and Marketing Cancer, Kisqali, NHS, Novartis, Scotland, breast cancer, pharma

NHS patients in Scotland will soon be able to access Novartis’ CDK4/6 inhibitor Kisqali (ribociclib) after the Scottish Medicines Consortium …

News
funk

Lonza CEO to step down in 2020

November 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, appointment

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to step down from the role …

News

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

November 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Working Life, feature, pharma

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was …

Feature
https__cdn

NHS to utilise first-ever cannabis-based therapies following NICE recommendation of two GW Pharma drugs

November 11, 2019
Sales and Marketing Epidyolex, GW Pharma, NHS, Sativex, pharma

The NHS is authorised to use its first two cannabis-based medicines for routine use after NICE saw fit to recommend …

News
roche

Roche’s risdiplam hits main goal in spinal muscular atrophy type 2 or 3

November 11, 2019
Research and Development, Sales and Marketing Roche, pharma, risdiplam, spinal muscular atrophy

Roche has lifted the curtain on new data which shows that its investigational survival motor neuron-2 (SMN2) splicing modifier risdiplam …

News
novartis_window

Novartis reveals strong Phase 2b data for tropifexor in non-alcoholic steatohepatitis

November 11, 2019
Research and Development, Sales and Marketing Novartis, nash, non-alcoholic steatohepatitis, pharma

The latest findings have been revealed from the final stage of Novartis’ Phase 2b evaluation of its non-bile acid FXR …

News
shutter

AnaptysBio’s etokimab fails in moderate-to-severe atopic dermatitis

November 11, 2019
Sales and Marketing AnaptysBio; atopic dermatitis, pharma

AnaptysBio has announced disappointing new Phase 2b data for its anti-IL-33 candidate etokimab in the treatment of moderate-to-severe atopic dermatitis. …

News

Celgene and Acceleron’s Reblozyl secures FDA approval for anaemia in beta thalassaemia

November 11, 2019
Sales and Marketing Acceleron, Celgene, Reblozyl, beta thalassaemia, pharma

The FDA has moved to authorise Celgene and Acceleron Pharma’s Reblozyl (luspatercept-aamt) in the treatment of anaemia associated with the …

News
bavencio

Pfizer and Merck KGaA’s Bavencio falls short of primary endpoint in Phase 3 gastric cancer trial

November 8, 2019
Medical Communications, Research and Development Bavencio, Merck KGaA, Pfizer, pharma

Pfizer and Merck KGaA’s EMD Serono have lifted the lid on new Phase 3 data for Bavencio (avelumab) in the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In our rundown of the week’s most popular stories, President Donald Trump has named his first choice for the top …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026